Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study

OBJECTIVES: To analyse the effect of targeted therapies, either biological (b) disease-modifying antirheumatic drugs (DMARDs), targeted synthetic (ts) DMARDs and other factors (demographics, comorbidities or COVID-19 symptoms) on the risk of COVID-19 related hospitalisation in patients with inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales: Álvaro Gracia, Jose María, Sanchez-Piedra, Carlos, Manero, Javier, Ruiz-Lucea, María Ester, López-Vives, Laura, Bohorquez, Cristina, Martinez-Barrio, Julia, Bonilla, Gema, Vela, Paloma, García-Villanueva, María Jesús, Navío-Marco, María Teresa, Pavía, Marina, Galindo, María, Erausquin, Celia, Gonzalez-Gay, Miguel A, Rua-Figueroa, Inigo, Pego-Reigosa, Jose M, Castrejon, Isabel, Sanchez-Costa, Jesús T, González-Dávila, Enrique, Diaz-Gonzalez, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662584/
https://www.ncbi.nlm.nih.gov/pubmed/34887346
http://dx.doi.org/10.1136/rmdopen-2021-001925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662584/
https://www.ncbi.nlm.nih.gov/pubmed/34887346
http://dx.doi.org/10.1136/rmdopen-2021-001925

Ejemplares similares